Cargando…
Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”
Diabetic nephropathy (DN) is the main cause of end-stage renal disease. DN is a complex disease mediated by genetic and environmental factors, and many cellular and molecular mechanisms are involved in renal damage in diabetes. There are no biomarkers that reflect the severity of the underlying rena...
Autores principales: | Ruiz-Ortega, Marta, Rodrigues-Diez, Raul R., Lavoz, Carolina, Rayego-Mateos, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141346/ https://www.ncbi.nlm.nih.gov/pubmed/32192024 http://dx.doi.org/10.3390/jcm9030813 |
Ejemplares similares
-
Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?
por: Lavoz, Carolina, et al.
Publicado: (2020) -
Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-β-Independent Process
por: Rodrigues Díez, Raúl, et al.
Publicado: (2010) -
VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy
por: Lavoz, Carolina, et al.
Publicado: (2020) -
Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation
por: Lavoz, Carolina, et al.
Publicado: (2012) -
Inflammatory and Fibrotic Mediators in Renal Diseases
por: Rayego-Mateos, Sandra, et al.
Publicado: (2019)